Dallas, TX -- (SBWire) -- 09/21/2010 -- ReportsandReports announce The Top 10 Eastern European Pharmaceutical Companies: Growth strategies, performance and SWOT analyses Market Research Report in its Store.
Browse complete Report at: http://www.reportsandreports.com/market-reports/the-top-10-eastern-european-pharmaceutical-companies-growth-stra/
The Eastern European pharmaceutical companies comprise both Eastern Europe-based and MNCs. This chapter provides an insight into the current state of Eastern European pharmaceutical industry as well as the evolving trends. It also provides the competitive landscape of the industry based on financial and operational (revenue growth over the last five years, exposure to major markets and presence in major therapeutic areas) parameters in the Eastern European region.
The report also includes profiles of the top ten companies in the region and also gives a brief summary of top 11 to 20 players. The top 10 companies in the Eastern European pharmaceutical industry were assessed on following parameters:
• Each company’s market share in the Eastern European pharmaceutical market;
• Each company’s marketed products, geographic and therapeutic focus;
• Each company’s growth strategies and major acquisitions and divestments in this market;
• Key mergers and acquisitions formed by these companies;
• Business-related strengths and weaknesses of these companies, and insights into the opportunities and threats facing them.
Key features of this report
• Market dynamics of the Eastern European pharmaceutical market during the period 2004-08.
• Key market drivers and resistors.
• Trends of the Eastern European pharmaceutical market.
• Identification of the top 10 players in the Eastern European pharmaceutical market.
• Company analysis and market share of the top 10 players in the Eastern European pharmaceutical market.
Scope of this report
• Learn from the strategies of the Eastern European pharmaceutical companies to target future growth markets effectively, avoid their mistakes, replicate their successes and learn of the threats they face.
• Benchmark your performance against the leading Eastern European pharmaceutical companies using market share data by company and comprehending their strategies.
• Understand the major issues affecting the Eastern European pharmaceutical market.
• Predict the key growth areas in the Eastern European pharmaceuticals market arising from the government’s initiative to promote generics in the region.
Key Market Issues
• Parallel trade: Increasing incidence of parallel traded products will impact companies operating in the region resulting in potential loss of sales eventually affecting cash flows and bringing down innovation in drug development.
• Complex pricing: Complex drug pricing, reimbursement and purchasing policies will affect the development of new drugs thus affecting the growth of Eastern European pharmaceutical market.
• Insufficient funds: Inadequate funding from the government may slowdown the development of the pharmaceutical industry in Eastern Europe.
• Regulatory hurdles: Increasing due diligence and compliance with standards leads to cost overrun and delay in new product launches.
Key findings from this report
•The Eastern European market is valued at $25,417m as of 2008, which is an increase of 19.9% over 2007. The industry witnessed a CAGR of 19.6% during 2004–08.
• Poland, Russia and Hungary lead the Eastern European pharmaceutical market and together contributed 62.1% of total market value in 2008.
• Novartis lead the Eastern European pharmaceutical market with a market share of 7.1% in 2008, followed by Sanofi-Aventis (6.1%) and GSK (4.9%).
• Parallel trade in Eastern Europe plays an important role influencing the multi-nationals’ branded products, which results in potential loss of sales and brings down the activity of innovative drug development.
Key questions answered
• What was the market size of the Eastern European pharmaceutical market in 2008?
• What are the trends in the Eastern European pharmaceutical market?
• Who are the top 10 players in the market?
• What is the market share of each of the companies?
• What are the growth strategies of the top 10 companies?
Table of Contents
The Top 10 Eastern European Pharmaceutical Companies
Executive summary
Industry overview
Novartis
Sanofi-Aventis
GlaxoSmithKline (GSK)
Servier
Roche
Pfizer
Bayer
Teva
Zentiva
Krka
Chapter 1 Introduction
What is this report about?
Methodology
Chapter 2 Industry overview
Summary
Introduction
Market dynamics
Eastern European market: size and growth
Parallel trade in Eastern Europe
Key market drivers and resistors
Competitive landscape
Competitive position of the top 10 companies
Comparative analysis of the top 10 companies
Trends
Consolidation underway
Increasing use of generics
Rise of value added generics and biosimilars
Cancer market represents strong commercial opportunity
Increasing presence of biotechnology
Chapter 3 Novartis
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Focus on biosimilars
Strengthening its oncology portfolio
Strengthening presence in Romania
Growing business by forging alliances and partnerships
Acquisitions and divestments
SWOT analysis
Chapter 4 Sanofi-Aventis
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Focusing on external collaborations for business development
Acquisitions and divestments
SWOT analysis
Chapter 5 GSK
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Investing in product capabilities and R&D
Partnerships fostering growth
Expanding product portfolio through new drug launches
Acquisitions and divestments
SWOT analysis
Chapter 6 Servier
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Expanding production capacity and establishing innovative drug development centers
Partnerships and alliances to fuel growth
Acquisitions and divestments
SWOT analysis
Chapter 7 Roche
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Sustaining sales growth for major oncology franchises through lineextensions
Diversifying into new therapeutic areas beyond oncology
Acquisitions and divestments
SWOT analysis
Chapter 8 Pfizer
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Expanding in the under-penetrated Russian market
Acquisitions and divestments
SWOT analysis
Chapter 9 Bayer
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Realigning focus in healthcare to improve long-term profitability
New product development to drive margins in Eastern Europe
Acquisitions and divestments
SWOT analysis
Chapter 10 Teva
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Leveraging the biosimilar opportunity in Europe
Investing in niche specialty areas to drive growth
Acquisitions and divestments
SWOT analysis
Chapter 11 Zentiva
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
Strengthening geographical footprint
Improving efficiency to drive profitable growth
Acquisitions and divestments
SWOT analysis
Chapter 12 Krka
Summary
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Growth strategies
New product launches fostering growth
Expanding production capacity of tablets and injectables and investing
R&D
Fortifying its vertical integrated business to cut manufacturing costs
Acquisitions and divestments
SWOT analysis
Chapter 13 11–20 companies
AstraZeneca
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Gedeon Richter
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Menarini
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Schering-Plough
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Johnson & Johnson (J&J)
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Eli Lilly
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Polpharma
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Boehringer Ingelheim
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Novo Nordisk
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Merck & Co.
Company overview
Geographic focus
Marketed products
Therapeutic focus
Research and development
Chapter 14 Appendix
Glossary
Index
Browse complete Report at: http://www.reportsandreports.com/market-reports/the-top-10-eastern-european-pharmaceutical-companies-growth-stra/
Browse all Banking and Financial Services Market Research Reports at: http://www.reportsandreports.com/market-research/banking-services/
Browse all Datamonitor Market Research Reports at:
http://www.reportsandreports.com/Publishers/datamonitor/
Browse all Newly Published Market Research Reports at:
http://www.reportsandreports.com/LatestReport.aspx
Related Reports:
The Top 10 European Utility Companies: Growth strategies, performance and SWOT analyses
http://www.reportsandreports.com/market-reports/the-top-10-european-utility-companies-growth-strategies-perform/
The Top 10 Pharmaceutical Companies in India: Growth strategies, performance and SWOT analyses
http://www.reportsandreports.com/market-reports/the-top-10-pharmaceutical-companies-in-india-growth-strategies-/
The Top 10 Cardiovascular Device Companies: Market trends, growth strategies, and SWOT analyses
http://www.reportsandreports.com/market-reports/the-top-10-cardiovascular-device-companies-market-trends-growth/
About Reports and Reports
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/
The Top 10 Eastern European Pharmaceutical Companies: Growth Strategies, Performance and SWOT Analyses Now Available at ReportsandReports
The Eastern European pharmaceutical companies comprise both Eastern Europe-based and MNCs. This chapter provides an insight into the current state of Eastern European pharmaceutical industry as well as the evolving trends.